Kenji Hibi
Yokohama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
A phase II study of bevacizumab with modified OPTIMOX1 as first-line therapy for metastatic colorectal cancer: the TCOG-GI 0802 study.
Journal: Investigational new drugs
Published: March 19, 2015
Serum vimentin methylation as a potential marker for colorectal cancer.
Journal: Anticancer research
Published: July 31, 2014
p16 Methylation is frequently detected in the serum of metastatic colorectal cancer patients.
Journal: Hepato-gastroenterology
Published: June 06, 2014
Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer
Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: July 19, 2013
Methylation of the HACE1 gene is frequently detected in hepatocellular carcinoma.
Journal: Hepato-gastroenterology
Published: June 05, 2013
Methylation of the WNT5A gene is frequently detected in early gastric carcinoma.
Journal: Hepato-gastroenterology
Published: November 27, 2012
Methylation of the UNC5C gene is frequently detected in hepatocellular carcinoma.
Journal: Hepato-gastroenterology
Published: November 27, 2012
FBN2 methylation is detected in the serum of colorectal cancer patients with hepatic metastasis.
Journal: Anticancer research
Published: October 13, 2012
Expression levels of thymidylate synthase, dihydropyrimidine dehydrogenase, and thymidine phosphorylase in patients with colorectal cancer.
Journal: Anticancer research
Published: May 18, 2012
Methylation of the DFNA5 gene is frequently detected in colorectal cancer.
Journal: Anticancer research
Published: April 12, 2012
Detection of vimentin methylation in the serum of patients with gastric cancer.
Journal: Anticancer research
Published: March 09, 2012
Last Updated: 09/26/2026